Literature DB >> 31103249

Molecular biology of human T cell leukemia virus.

Lee Ratner1.   

Abstract

Human T cell leukemia virus type 1 (HTLV-1) is a horizontally transmitted virus infection of CD4+ lymphocytes which causes adult T cell leukemia-lymphoma (ATLL) and HTLV-associated myelopathy (HAM). The viral genome encodes two oncoproteins, transactivator protein (Tax) and helix basic zipper protein (HBZ), which are considered tumor initiator and maintenance factors, respectively. Tax is the primary inducer of clonal infected T cell expansion, and genetic instability. The immune response to Tax results in the selection of cells with little or no Tax expression, which have undergone genetic and epigenetic alterations that promote T cell activation, proliferation, and resistance to apoptosis. This selection of malignant cells occurs over several decades in 5% of infected individuals. Novel insights into the molecular details of each of these events has led to targeted therapies for ATLL.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31103249      PMCID: PMC6801043          DOI: 10.1053/j.semdp.2019.04.003

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  53 in total

Review 1.  Epigenetic Dysregulation in Virus-Associated Neoplasms.

Authors:  Janos Minarovits; Anett Demcsák; Ferenc Banati; Hans Helmut Niller
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.

Authors:  D W Ballard; E Böhnlein; J W Lowenthal; Y Wano; B R Franza; W C Greene
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

3.  IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.

Authors:  Juan Carlos Ramos; Phillip Ruiz; Lee Ratner; Isildinha M Reis; Carlos Brites; Celia Pedroso; Gerald E Byrne; Ngoc L Toomey; Valentine Andela; Edward W Harhaj; Izidore S Lossos; William J Harrington
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

4.  An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.

Authors:  Mathew A Cherian; Sydney Olson; Hemalatha Sundaramoorthi; Kitra Cates; Xiaogang Cheng; John Harding; Andrew Martens; Grant A Challen; Manoj Tyagi; Lee Ratner; Daniel Rauch
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

5.  Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.

Authors:  A Lopez-Girona; D Mendy; T Ito; K Miller; A K Gandhi; J Kang; S Karasawa; G Carmel; P Jackson; M Abbasian; A Mahmoudi; B Cathers; E Rychak; S Gaidarova; R Chen; P H Schafer; H Handa; T O Daniel; J F Evans; R Chopra
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

6.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

Review 7.  HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Viruses       Date:  2011-07-08       Impact factor: 5.048

Review 8.  HTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication.

Authors:  Kazumi Nakano; Toshiki Watanabe
Journal:  Viruses       Date:  2016-02-24       Impact factor: 5.048

9.  The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis.

Authors:  Anat Melamed; Hiroko Yaguchi; Michi Miura; Aviva Witkover; Tomas W Fitzgerald; Ewan Birney; Charles Rm Bangham
Journal:  Elife       Date:  2018-06-26       Impact factor: 8.140

Review 10.  Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Masao Matsuoka
Journal:  Retrovirology       Date:  2016-03-15       Impact factor: 4.602

View more
  4 in total

1.  HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models.

Authors:  Victoria Maksimova; Susan Smith; Jaideep Seth; Cameron Phelps; Stefan Niewiesk; Yorifumi Satou; Patrick L Green; Amanda R Panfil
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 2.  A role for an HTLV-1 vaccine?

Authors:  Lee Ratner
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 3.  MiR-150 in HTLV-1 infection and T-cell transformation.

Authors:  Donna M D'Agostino; Vittoria Raimondi; Micol Silic-Benussi; Vincenzo Ciminale
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 4.  Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.

Authors:  Victoria Maksimova; Amanda R Panfil
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.